We further evaluated the ability of humoral factors present in plasma from patients with COVID-19 to promote procoagulant changes in the endothelium by measuring factor Xa and thrombin generation on endothelial cells following exposure to COVID-19 plasma. This evidence concerns the gene F10 and COVID-19.